Clinical trial

A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

NCT03807778

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2019-02-04

PhasePHASE1

Study timeline

Study start (actual)2019-02-04Date precision: day

Registry last updated2026-05-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Interventions

MobocertinibDRUG · verified · RxNorm: mobocertinib

Sponsors & collaborators

Takedalead sponsor

Mapped research locations

OsakaJapan1 FukuokaJapan1 NagoyaAichi-ken, Japan1 SapporoHokkaido, Japan1 YokohamaKanagawa, Japan1 KyotoJapan1 HiroshimaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03807778 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.